Erika Prinz

ABO mismatch increases transplant‐related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation

Nina Worel, Peter Kalhs, Felix Keil et al. · Transfusion · 2003 · 73 citations · Full text

Adverse drug reactions (ADRs) associated with hospital admissions – elderly female patients are at highest risk

C. Hofer-Dueckelmann, Erika Prinz, W. Beindl et al. · International Journal of Clinical Pharmacology and Therapeutics · 2011 · 66 citations

RAPID ESTABLISHMENT OF LONG-TERM CULTURE-INITIATING CELLS OF DONOR ORIGIN AFTER NONMYELOABLATIVE ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION, AND SIGNIFICANT PROGNOSTIC IMPACT OF DONOR T-CELL CHIMERISM ON STABLE ENGRAFTMENT AND PROGRESSION-FREE SURVIVAL

Felix Keil, Erika Prinz, Karin S. Moser et al. · Transplantation · 2003 · 43 citations

Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb® immunoadsorption

Werner Rabitsch, Paul Knöbl, Erika Prinz et al. · Bone Marrow Transplantation · 2003 · 35 citations

Immunohematology, Cell Therapy, Transplantation +10

Bone Marrow Microvessel Density and it's Prognostic Significance in AML

Werner Rabitsch, Wolfgang R. Sperr, Klaus Lechner et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2004 · 35 citations

Hematological Malignancy, Transplantation, Marrow Transplantation +15